Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

209 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms.
Navab M, Reddy ST, Van Lenten BJ, Fogelman AM. Navab M, et al. Nat Rev Cardiol. 2011 Apr;8(4):222-32. doi: 10.1038/nrcardio.2010.222. Epub 2011 Feb 8. Nat Rev Cardiol. 2011. PMID: 21304474 Review.
Oral administration of an Apo A-I mimetic Peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol.
Navab M, Anantharamaiah GM, Hama S, Garber DW, Chaddha M, Hough G, Lallone R, Fogelman AM. Navab M, et al. Circulation. 2002 Jan 22;105(3):290-2. doi: 10.1161/hc0302.103711. Circulation. 2002. PMID: 11804981
Oxidized lipids as mediators of coronary heart disease.
Navab M, Hama SY, Reddy ST, Ng CJ, Van Lenten BJ, Laks H, Fogelman AM. Navab M, et al. Curr Opin Lipidol. 2002 Aug;13(4):363-72. doi: 10.1097/00041433-200208000-00003. Curr Opin Lipidol. 2002. PMID: 12151851 Review.
Influenza infection promotes macrophage traffic into arteries of mice that is prevented by D-4F, an apolipoprotein A-I mimetic peptide.
Van Lenten BJ, Wagner AC, Anantharamaiah GM, Garber DW, Fishbein MC, Adhikary L, Nayak DP, Hama S, Navab M, Fogelman AM. Van Lenten BJ, et al. Among authors: navab m. Circulation. 2002 Aug 27;106(9):1127-32. doi: 10.1161/01.cir.0000030182.35880.3e. Circulation. 2002. PMID: 12196340
ATP-binding cassette transporter 1 participates in LDL oxidation by artery wall cells.
Reddy ST, Hama S, Ng C, Grijalva V, Navab M, Fogelman AM. Reddy ST, et al. Among authors: navab m. Arterioscler Thromb Vasc Biol. 2002 Nov 1;22(11):1877-83. doi: 10.1161/01.atv.0000035700.82829.2a. Arterioscler Thromb Vasc Biol. 2002. PMID: 12426219
Identification of genes induced by oxidized phospholipids in human aortic endothelial cells.
Reddy ST, Grijalva V, Ng C, Hassan K, Hama S, Mottahedeh R, Wadleigh DJ, Navab M, Fogelman AM. Reddy ST, et al. Among authors: navab m. Vascul Pharmacol. 2002 Apr;38(4):211-8. doi: 10.1016/s1537-1891(02)00171-4. Vascul Pharmacol. 2002. PMID: 12449017
Oral synthetic phospholipid (DMPC) raises high-density lipoprotein cholesterol levels, improves high-density lipoprotein function, and markedly reduces atherosclerosis in apolipoprotein E-null mice.
Navab M, Hama S, Hough G, Fogelman AM. Navab M, et al. Circulation. 2003 Oct 7;108(14):1735-9. doi: 10.1161/01.CIR.0000089375.60050.35. Epub 2003 Sep 22. Circulation. 2003. PMID: 14504179
Human apolipoprotein AI mimetic peptides for the treatment of atherosclerosis.
Navab M, Anantharamaiah GM, Reddy ST, Van Lenten BJ, Hough G, Wagner A, Nakamura K, Garber DW, Datta G, Segrest JP, Hama S, Fogelman AM. Navab M, et al. Curr Opin Investig Drugs. 2003 Sep;4(9):1100-4. Curr Opin Investig Drugs. 2003. PMID: 14582455 Review.
Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment.
Ansell BJ, Navab M, Hama S, Kamranpour N, Fonarow G, Hough G, Rahmani S, Mottahedeh R, Dave R, Reddy ST, Fogelman AM. Ansell BJ, et al. Among authors: navab m. Circulation. 2003 Dec 2;108(22):2751-6. doi: 10.1161/01.CIR.0000103624.14436.4B. Epub 2003 Nov 24. Circulation. 2003. PMID: 14638544 Clinical Trial.
The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL.
Navab M, Ananthramaiah GM, Reddy ST, Van Lenten BJ, Ansell BJ, Fonarow GC, Vahabzadeh K, Hama S, Hough G, Kamranpour N, Berliner JA, Lusis AJ, Fogelman AM. Navab M, et al. J Lipid Res. 2004 Jun;45(6):993-1007. doi: 10.1194/jlr.R400001-JLR200. Epub 2004 Apr 1. J Lipid Res. 2004. PMID: 15060092 Review.
209 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback